Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • NPPA fixes retail...

NPPA fixes retail price of 11 formulations, Details

Medical Dialogues TeamWritten by Medical Dialogues Team Published On 2021-07-10T13:58:53+05:30  |  Updated On 19 Oct 2023 5:28 PM IST
NPPA fixes retail price of 11 formulations, Details
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, has fixed the retail price of 11 formulations, including those used to treat dry cough, high blood pressure, and type 2 diabetes.

These include Eris Lifescience's blood-pressure lowering medicine Telmisartan and Nebivolol fixed dose combination drug, Akums, Cadila Pharmaceutical's Telmisartan, Amlodipine and Hydrochlorathiazide Fixed Dose Combination (FDC) drug that is used in the treatment of Hypertension.

In addition to this, Agron Remedies, Cadila's antidiabetic FDC of Glimeperide and Metformin HCL (SR) and Windlas Biotech, Eris Lifescience's popular anti-diabetic treatment combination Glimeperide, Pioglitazone, and Metformin HCL (SR) Tablet are also on the list.

Further, the list contains East African (India) Overseas/Cadila Pharmaceutical's combination medicine Dextromethorphan Hydrobromide and Chlorpheniramine Meleate Syrup which is used in the treatment of dry cough, Shiv Industries/Profic Organic's Paracetamol plus Methocarbamol plus Diclofenac Potassium tablet combination , Akums/Cipla's Vitamin D3 Oral Drops.

Also Read:NPPA panel fixes price of Human Coagulation Factor IX,Details

This price fixation is followed by the decisions made by the National Pharmaceutical Pricing Authority at its 89th Authority meeting held on 28th of June 2021, where the Authority discussed retail price fixation of listed drugs.

In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 701(E) dated 10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (NPPA), hereby fixed, the price as specified in column (6) of the table herein below as the retail price, exclusive of goods and services tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

Sl.

No.

Name of the Formulation / Brand

Name

Strength

Unit

Manufacturer & Marketing Company

Retail Price

(Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

1.

Telmisartan + Nebivolol Tablet

Each uncoated Bilayered Tablet Contains: Telmisartan IP 40 mg

Nebivolol Hydrochloride IP

Equivalent to Nebivolol 5 mg

1

Tablet

M/s Eris Lifesciences Limited

13.61

2.

Glimeperide + Pioglitazone + Metformin HCL (SR) Tablet

Each uncoated bilayered tablet contains: Glimeperide IP 2mg

Pioglitazone Hydrochloride IP eq. to Pioglitazone 15mg

Metformin Hydrochloride IP 1000mg (in sustained release form)

1

Tablet

M/s Windlas Biotech Pvt. Ltd. / M/s Eris Lifesciences Limited

12.85

3.

Glimeperide + Pioglitazone + Metformin HCL (SR) Tablet

Each uncoated bilayered tablet contains: Glimeperide IP 1mg

Pioglitazone Hydrochloride IP eq. to Pioglitazone 15mg

Metformin Hydrochloride IP 1000mg (in

sustained release form)

1

Tablet

M/s Windlas Biotech Pvt. Ltd. / M/s Eris Lifesciences Limited

8.73

4.

Glimeperide + Metformin HCL (SR) Tablet

Each uncoated tablet contains: Glimeperide IP 2mg

Metformin Hydrochloride IP 1000mg (in

sustained release form)

1

Tablet

M/s M/s Agron Remedies Private Limited / M/s Cadila

Pharmaceuticals Ltd.

9.44

5.

Glimeperide + Metformin HCL (SR) Tablet

Each uncoated tablet contains: Glimeperide IP 1mg

Metformin Hydrochloride IP 1000mg (in sustained release form)

1

Tablet

M/s M/s Agron Remedies Private Limited / M/s Cadila

Pharmaceuticals Ltd.

6.86

6.

Dextromethorphan Hydrobromide + Chlorpheniramine

Meleate Syrup

Each 5ml contains:

Dextromethorphan Hydrobromide IP 10mg Chlorpheniramine Meleate IP 2mg

1 ML

M/s East African (India) Overseas / M/s Cadila

Pharmaceuticals Ltd.

0.64

7.

Esomeprazole & Domperidone sustained release capsule

Each hard gelatine capsule contains: Esomeprazole Magnesium IP eq. to Esomeprazole 40mg (as enteric coated pellets),

Domperidone IP 30mg (as sustained

release pellets)

1

Capsul e

M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s Jagsonpal Pharmaceuticals Ltd.

10.20

8.

Telmisartan + Amlodipine + Hydrochlorathiazide Tablet

Each film coated tablet contains: Telmisartan IP 40mg,

Amlodipine Besylate IP eq. to Amlodipine 5mg

1

Tablet

M/s Akums Drugs & Pharmaceuticals Ltd.

/ M/s Cadila Pharmaceuticals Ltd.

9.56


Sl.

No.

Name of the Formulation / Brand

Name

Strength

Unit

Manufacturer & Marketing Company

Retail Price

(Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

Hydrochlorothiazide IP 12.50 mg

9.

Nebivolol Hydrochloride

+ Telmisartan Tablet

Each uncoated bilayered tablet contains: Nebivolol Hydrochloride IP eq. to Nebivolol 5mg

Telmisartan IP 40mg

1

Tablet

M/s Windlas Biotech limited / M/s Eris Lifesciences Limited

13.61

10.

Vitamin D3 Oral Drops

Each ml contains:

Cholecalciferol (Vitamin D3) IP 800IU

1 ML

M/s Akums Drugs & Pharmaceuticals Limited / M/s Cipla

Limited

5.06

11.

Paracetamol + Methocarbamol + Diclofenac Potassium

tablet

Each Film coated tablet contains: Paracetamol IP 325mg Methocarbamol IP 500mg

Diclofenac Potassium BP 50mg tablet

1

Tablet

M/s Shiv Industries / M/s Profic Organic Limited

7.96

The notification further added;

(a) The manufacturer of above mentioned formulations i.e. "new drug" under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add goods and services tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.

Also Read: NPPA exempts Torrent Pharma Tapentadol Nasal Spray from price cap for 5 years
nppaciplacadilaeris lifesciencesakums drugglimepirideMetforminpioglitazionevitamin D3 oral dropdiabetes drug
Medical Dialogues Team
Medical Dialogues Team
    Show Full Article
    Next Story

    Editorial

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    View All

    Journal Club Today

    Study Reveals Why Your Immune System Works Better in Daylight

    Study Reveals Why Your Immune System Works Better in Daylight

    View All

    Health News Today

    Health Bulletin 30/May/2025

    Health Bulletin 30/May/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok